Evidence map›Paper›PMID 40547548›Full record

ArticleWorld journal of gastrointestinal endoscopy2025

Advantages of new generation colonoscopes on adenoma detection: A propensity-score matching study.

Toshihiro Nishizawa, Osamu Toyoshima, Shuntaro Yoshida, Yoshiyuki Takahashi, Hideki Nakagawa, Hiroya Mizutani, Yosuke Kataoka, Takamitsu Kanazawa, Hirotoshi Ebinuma, Keisuke Hata

Abstract read
In one paragraph

Article in World journal of gastrointestinal endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Toshihiro NishizawaDepartment of Gastroenterology and Hepatology, International University of Health and Welfare, Narita Hospital, Narita 286-8520, Japan.
Osamu ToyoshimaDepartment of Gastroenterology, Toyoshima Endoscopy Clinic, Tokyo 157-0066, Japan. t@ichou.com.
Shuntaro YoshidaDepartment of Gastroenterology, Toyoshima Endoscopy Clinic, Tokyo 157-0066, Japan.
Yoshiyuki TakahashiDepartment of Gastroenterology, Toyoshima Endoscopy Clinic, Tokyo 157-0066, Japan.
Hideki NakagawaDepartment of Gastroenterology, Toyoshima Endoscopy Clinic, Tokyo 157-0066, Japan.
Hiroya MizutaniDepartment of Gastroenterology, Toyoshima Endoscopy Clinic, Tokyo 157-0066, Japan.
Yosuke KataokaDepartment of Gastroenterology, Toyoshima Endoscopy Clinic, Tokyo 157-0066, Japan.
Takamitsu KanazawaDepartment of Gastroenterology, Toyoshima Endoscopy Clinic, Tokyo 157-0066, Japan.
Hirotoshi EbinumaDepartment of Gastroenterology and Hepatology, International University of Health and Welfare, Narita Hospital, Narita 286-8520, Japan.
Keisuke HataDepartment of Gastroenterology, Toyoshima Endoscopy Clinic, Tokyo 157-0066, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecently, Olympus Corporation released new scopes (XZ1200/EZ1500). However, there have been few reports on this topic, although improvement in adenoma detection rate (ADR) by texture and color enhancement imaging (TXI) or computer-aided detection system (CAD) has been reported.

aimTo investigate the effects of the scope on the detection of adenomas and sessile serrated lesions (SSLs).

methodsThe subjects were patients who underwent pancolonic chromoendoscopy using the EVIS X1 video system center between May 2023 and October 2024. The patients were divided into the new (CF-XZ1200/CF-EZ1500) and 290 series (CF-HQ290Z/PCF-H290Z) groups. Propensity score matching was performed for age, sex, examination purpose, endoscopist, preparation, TXI use, and CAD use. The effects of the scope were analyzed in terms of the ADR, SSL detection rate (SDR), and mean number of adenomas per colonoscopy (APC).

resultsOf the 7014 patients enrolled, 2138 pairs were extracted by propensity score matching (mean age 55.4 years, 45.5% male). The new scopes group had a significantly higher ADR than the 290 series group [51.5%

conclusionIn conclusion, the new scope (CF-XZ1200/CF-EZ1500) enhanced the detection of adenomas and SSLs compared to the old ones (290 series).

Indexed as

Adenoma detection rateColonoscopyEVIS X1New generationPropensity-score matching

Identifiers

PMID40547548
PMCPMC12179962

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.